Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dpl Inhibitors

Doppel protein (Dpl), also known by its gene name PRND, is a prion-like protein that, unlike its notorious counterpart PrP^C, has been less implicated in transmissible spongiform encephalopathies but holds significant interest for its roles in neurobiology and cellular homeostasis. Dpl is predominantly expressed in the testis and, to a lesser extent, in other tissues, suggesting a role in reproductive biology as well as potential fumatchnctions in neural development and maintenance. The exact physiological role of Dpl remains partially elucidated, but emerging research suggests it may be involved in cell signaling pathways, cellular differentiation, and possibly the regulation of apoptosis. The protein's structure shares similarity with prion proteins, including a notable PrP-like domain, which implies that it may adopt multiple conformational states that influence its biological activity. Understanding the functional dynamics of Dpl is crucial for deciphering its contribution to normal cellular processes and its potential involvement in disease states, especially those related to neurodegeneration and reproductive biology. The inhibition of Dpl involves a complex interplay of molecular interactions and regulatory mechanisms that modulate its expression, stability, and function. Inhibition at the genetic level can be achieved through the suppression of PRND gene expression, utilizing techniques such as RNA interference (RNAi) or CRISPR-Cas9 mediated gene editing, which reduce Dpl protein levels and consequently its activity within cells. Post-translational modifications (PTMs) of Dpl, including phosphorylation, ubiquitination, or sumoylation, represent another layer of regulation that can influence its cellular localization, degradation, or interaction with other proteins, leading to an inhibition of its functional properties. Furthermore, the interaction of Dpl with specific binding partners or cofactors may also modulate its activity; thus, disrupting these interactions could serve as a mechanism for inhibition.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide is an inhibitor of protein biosynthesis in eukaryotic organisms, functioning by interfering with the translocation step in protein synthesis, thus potentially reducing the synthesis of Dpl protein.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a kinase that is a key regulator of protein synthesis and cell growth. By inhibiting mTOR, rapamycin can decrease overall protein synthesis, which includes downregulation of proteins such as Dpl.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent inhibitor of protein kinases, affecting many signaling pathways, including those that may regulate Dpl expression or function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is an inhibitor of the PI3K/Akt pathway, a signaling route that can control protein synthesis and turnover. Inhibition of this pathway can modulate the levels of various proteins, potentially affecting Dpl levels.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a specific inhibitor of MEK, which is part of the MAPK/ERK pathway. The MAPK/ERK pathway can regulate gene expression, and inhibition by U0126 could result in altered expression of Dpl.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

SB203580 specifically inhibits p38 MAPK, which might alter cellular stress responses and inflammation pathways, potentially influencing Dpl expression or stability.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which works similarly to U0126, potentially leading to changes in Dpl expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has been shown to affect multiple signaling pathways and could modulate the expression or function of proteins, including Dpl, through its effects on transcription factors and inflammatory pathways.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol can modulate sirtuin activity and the NF-κB pathway, among others, influencing protein expression and cell survival, which could affect Dpl levels indirectly.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate is a histone deacetylase inhibitor, which can change chromatin structure and gene expression. These changes can include the modulation of protein levels like Dpl.